This morning shares of Heartware Int'l (NASDAQ: HTWR) declined following reports from the FDA MUADE database that a Heartware HVAD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE